1. Case reports {#sec1}
===============

(1)64 years old male was referred to our clinic for assessment of dyspnea on exertion.His past medical history included hypertension and hyperlipidemia.His social history was significant for long standing smoking.His medications included Amlodipine 5 mg, Losartan 50 and Atorvastatin 40 mgPhysical examination: Normal S1,S2; grade 2/6 SM at LSB; EDM at Left 2nd ICS

Echo: Normal LV and RV function; dilated ascending aorta (4.5cm), moderate AI; mild TR; mild pulmonary hypertension (PA pressure 35--40 mmHg) 1 year later repeat Echo Normal LV and RV function; mild to moderate pulmonary hypertension (PA pressure 50--55 mmHg) Following year echo shows: Normal LV function but dilated RV with mildly reduced systolic function; moderately severe pulmonary hypertension (PA pressure 65--70 mmHg)

Underwent CT chest which revealed moderate to severe cardiomegaly; dilated MPA which can be seen in setting of pulmonary arterial HTN; areas of mosaic attenuation predominantly left upper lobe; no evidence of pulmonary fibrosis.

Underwent Right and Left heart catheterization which revealed:

Patent coronaries; PAP 83/25; mean PAP 49 mmHg; PCWP10 mmHg.

RA mean 7 mmHg; C.O. 2.8l/m; CI 1.6l/m/m2.

Findings suggestive of primary pulmonary hypertension.

Vasoreactivity test was negative (Epoprosterenol did not change mean PAP).

Pulmonary Wedge arteriography in right lower lobe suggesting arteriolar fibrosis.

Patient was started on Macitentan 10 mg po qd.

In about a week patient had acute shortness of breath and syncope.

Was transferred to nearest Hospital ER.

Echo performed in ER showed dilated right ventricle with severe hypokinesis with apical sparing (McConnell\'s sign); septal flattening; moderate TR with severe pulmonary hypertension ([Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}, [Fig. 4](#fig4){ref-type="fig"}, [Fig. 5](#fig5){ref-type="fig"}).Fig. 1Dilated right ventricle with severe hypokinesis with apical sparing (McConnell's sign)Parasternal long axis view.Fig. 1Fig. 2Septal flattening noted in parasternal short axis view.Fig. 2Fig. 3Dilated right ventricle with severe hypokinesis with apical sparing (McConnell's sign) Apical 4 chamber view.Fig. 3Fig. 4Moderate tricuspid regurgitation.Fig. 4Fig. 5Severe pulmonary hypertension.Fig. 5

CT showed pulmonary emboli.

Patient underwent thrombolysis and subsequent treatment with Xarelto 20 mg po qd for 6 months.

Repeat CT angio showed no evidence of thrombus.

Continued to be treated with Macitentan 10 mg po qd (ETA and ETB blocker).

Repeat Echo showed remarkable improvement in RV function with mild pulmonary hypertension (PA pressure 41--46 mmHg).

Most recent echo showed moderate pulmonary hypertension (PA pressure 50--55 mmHg).

Patient also felt dyspnea on exertion. Due to worsening of his symptom and his higher PA pressure, pulmonologist added Riociguat 0.5 mg po tid to his current regimen which is to be titrated up as tolerated.

CT chest was performed which showed acute pulmonary emboli in left and right lower lobes and chronic pulmonary emboli in right upper lobe. The main pulmonary artery segment is dilated measuring up to 4.7 cm in diameter. Patient was treated with Eliquis 5 mg po bid with some resolution of symptoms.(2)70 years old male with history of DVT 2014 (CT angio at that time shows no pulmonary emboli) treated with Xarelto 20 mg po qd at that time. 3 years later, echo 11/17/19 showed dilated RV with moderate pulmonary hypertension (PA pressure 50--55 mmHg). Patient was referred to pulmonary specialist who obtained a V/Q scan which revealed evidence of pulmonary emboli. Based on these findings, he was deemed to have chronic thrombo-embolic pulmonary hypertension (CTEPH) and was treated with Riociguat 2.5 mg po tid. Subsequent echo done 10/24/18 showed improvement in his RV function with pulmonary hypertension in the range of mild severity (PA pressure 37--42 mmHg) with significant improvement in his symptoms

2. Discussion {#sec2}
=============

Pulmonary hypertension is now categorized into five groups based on pathological findings, hemodynamic characteristics, and management. Because of the multiple etiologies of pulmonary hypertension, a thorough diagnostic evaluation is essential in patients who present with symptoms (dyspnea, fatigue, chest pain, syncope, edema) so that appropriate therapy may be initiated.

Echocardiography plays a pivotal role in the initial diagnostic armametrium when a patient presents with such varied symptoms as listed above. In these two case reports, we wanted to elucidate the different echocardiographic findings which led to the diagnosis of two different forms of pulmonary hypertension.

In the first case, patient had primary pulmonary arterial hypertension which then had in situ thrombus formation within the dilated pulmonary arteries leading to acute pulmonary embolism which was detected on echocardiography with salient features of RV dilatation and RV hypokinesis McConnell\'s sign \[[@bib2]\] and severe pulmonary hypertension. Based on theses echo findings, patient was treated with IV heparin and subsequent warfarin. He was treated with endothelin receptor antagonist Bosentan \[[@bib3]\] with initial improvement in his symptoms. Then subsequently based on echo report of worsening pulmonary hypertension with RV dilation and increasing dyspnea on exertion, decision was made to add Riociguat \[[@bib4]\] for further improvement as per treatment protocol for pulmonary arterial hypertension. Patient was found to have recurrent pulmonary emboli superimposed on dilated pulmonary arteries, one of the proposed mechanisms for pulmonary embolism in patients with primary pulmonary hypertension \[[@bib5]\].

In the second case, echocardiography also played a pivotal role in the diagnosis of CTEPH by initially demonstrating worsening pulmonary hypertension. Thereafter patient underwent V/Q scan and right heart catheterization confirming the diagnosis. He was subsequently treated with Riociguat with improvement in echo findings and his symptoms.

To our knowledge these are the first case reports enumerating the pivotal role of echocardiography in clinical practice when we are at the crossroads of diagnostic dilemma with the myriad presentations of enigmatic pulmonary hypertension.

3. Conclusion {#sec3}
=============

Our cases are unique in that the patient in the first case was an elderly individual male patient who had primary pulmonary hypertension which is rare in this age group although recent data suggest it is present in 15% of elderly patients which is more frequent than previously recognized \[[@bib6]\]. The second case illustrates use of echocardiography in the institution of newer therapeutic modality in patients with CTEPH.

Echocardiography can play a major role in the diagnosis and management of pulmonary hypertension as we illustrated in our presentation of these case reports.

With better classification by WHO and advent of newer treatment modalities, echocardiography would continue to render tremendous help in the diagnosis and management of this enigmatic condition.

In our experience serial echocardiographic evaluation and a team approach between cardiologist and pulmonologist can be of paramount importance when we stand at the crossroad of management of this enigmatic disease.
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